Atherosclerotic heart disease of native coronary artery
ICD-10 I25.1 is a used to indicate a diagnosis of atherosclerotic heart disease of native coronary artery.
I25.1 refers to atherosclerotic heart disease of the native coronary artery, a condition characterized by the buildup of atherosclerotic plaques within the coronary arteries, leading to reduced blood flow to the heart muscle. Clinically, patients may present with symptoms such as angina pectoris, shortness of breath, or even myocardial infarction. The anatomy involved primarily includes the left and right coronary arteries, which supply blood to the heart. Disease progression often involves the gradual narrowing of these arteries, which can lead to ischemia and subsequent heart damage. Diagnostic considerations include patient history, physical examination, electrocardiograms (ECGs), stress testing, and imaging studies such as coronary angiography. The presence of risk factors such as hypertension, diabetes, hyperlipidemia, and smoking significantly contributes to the development and progression of this condition, necessitating early detection and management to prevent severe cardiovascular events.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
I25.1 covers atherosclerotic heart disease specifically affecting the native coronary arteries, including stable angina, unstable angina, and myocardial infarction resulting from coronary artery disease.
I25.1 should be used when there is clear documentation of atherosclerosis affecting the native coronary arteries, differentiating it from codes for other types of heart disease or unspecified conditions.
Documentation should include a detailed patient history, risk factor assessment, clinical findings, diagnostic test results, and treatment plans that specifically address atherosclerotic changes in the coronary arteries.
